Brief: Sunesis Pharmaceuticals Receives Compliance Letter From Nasdaq
18/09/2020 22:01
Sept 18 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS PHARMACEUTICALS INC - RECEIVED LETTER FROM NASDAQ
NOTIFYING THAT COMPANY HAD REGAINED COMPLIANCE
Source : (https://bit.ly/2RFd6E5)
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update